Sign inJoin waitlistJoin the waitlist

Muhammad Afzal

, Associate Program Director · Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital

Credentials: · · · · · · · ·

History

Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital
Present
Geisel School of Medicine
2021–Present
Geisel School of Medicine
Present

Hematology and Medical Oncology
Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital
2020–2023
The Ohio State University
2018
University of Illinois
2012–2015
King Edward Medical University
2008

Research

Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma
Journal for ImmunoTherapy of Cancer · 2018 · First of 3 authors · 146 citations
The association of PD-L1 expression with the efficacy of anti-PD-1/PD-L1 immunotherapy and survival of non-small cell lung cancer patients: a meta-analysis of randomized controlled…
Translational Lung Cancer Research · 2019 · 144 citations
Clinical outcomes in non-small-cell lung cancer patients receiving concurrent metformin and immune checkpoint inhibitors
Lung Cancer Management · 2019 · First of 4 authors · Corresponding · 74 citations

Keisuke Shirai
14 papers
Konstantin Dragnev
3 papers
TS
Tayyaba Sarwar
3 papers · 1 as a resident
Yenong Cao
3 papers
HH
Hamza Hashmi
2 papers · 2 as a fellow
Kathrine Cooper
2 papers · 2 as a fellow
NL
Nehal Lakhani
2 papers
Arief Suriawinata
1 paper
BW
Bret Wankel
1 paper · 1 as a resident
BL
Brian Lane
1 paper
CL
Caroline Lapp
1 paper · 1 as a resident
Christi Hayes
1 paper